{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T12:44:05Z","timestamp":1754397845100,"version":"3.37.3"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T00:00:00Z","timestamp":1685664000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T00:00:00Z","timestamp":1685664000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"not applicable"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Agents Cancer"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This report covers the case of 7 women affected by pathologies related to genital Herpesvirus and Papillomavirus. They were referred to the gynaecology outpatient clinic for colposcopic examination, and received pharmacological antiviral treatment. The patients presented clinical signs of genital Herpesvirus infections in the cervix and vulva. Cervical lesions and condylomatosis, which are characteristic of Papillomavirus infections were also detected, and patients underwent cervical cancer screening. Patients received oral and topical treatment with Acyclovir or oral treatment with Valacyclovir. During weekly or biweekly gynaecological follow-up visits, patients showed different times of remission of genital Herpesvirus. During the antiviral treatments, the vulvar and cervical Papillomavirus lesions also showed complete resolution with <jats:italic>restitutio ad integrum<\/jats:italic> of the tissues, and no recurrence at follow-up visits. Herpesvirus and Papillomavirus infections are often associated in genital infections and, as sexual transmitted infections, share the same risk factors. In the cases presented, the observed remission of HPV-related pathologies during Acyclovir and Valaciclovir treatments may suggest that antivirals are also effective in the treatment of HPV lesions. The cases described could pave the way for further investigations and clinical studies.\n<\/jats:p>","DOI":"10.1186\/s13027-023-00511-0","type":"journal-article","created":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T09:42:30Z","timestamp":1685698950000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Conventional therapy for genital herpesvirus and remission of HPV-related lesions: a case series"],"prefix":"10.1186","volume":"18","author":[{"given":"Maria","family":"Balestrieri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caterina","family":"Carnovale-Scalzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2687-8642","authenticated-orcid":false,"given":"Anna Rosa","family":"Garbuglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5163-2698","authenticated-orcid":false,"given":"Maria Vincenza","family":"Chiantore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5091-9272","authenticated-orcid":false,"given":"Luisa","family":"Accardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4737-374X","authenticated-orcid":false,"given":"Paola","family":"Di Bonito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,2]]},"reference":[{"key":"511_CR1","doi-asserted-by":"crossref","unstructured":"Majewska A, Mlynarczyk-Bonikowska B. 40 years after the registration of acyclovir: Do we need new anti-herpetic drugs? Int J Mol Sci. 2022;23(7).","DOI":"10.3390\/ijms23073431"},{"key":"511_CR2","unstructured":"WHO. WHO Guidelines for the Treatment of Genital Herpes simplex virus. WHO Libr. 2016;8(4):207\u201311."},{"issue":"3","key":"511_CR3","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1128\/CMR.00102-15","volume":"29","author":"E De Clercq","year":"2016","unstructured":"De Clercq E, Li G. Approved antiviral drugs over the past 50 years. Clin Microbiol Rev. 2016;29(3):695\u2013747.","journal-title":"Clin Microbiol Rev"},{"issue":"8","key":"511_CR4","doi-asserted-by":"publisher","first-page":"6710","DOI":"10.1128\/JVI.72.8.6710-6715.1998","volume":"72","author":"S-H Chen","year":"1998","unstructured":"Chen S-H, Cook WJ, Grove KL, Coen DM. Human thymidine kinase can functionally replace herpes simplex virus type 1 thymidine kinase for viral replication in mouse sensory ganglia and reactivation from latency upon explant. J Virol. 1998;72(8):6710\u20135.","journal-title":"J Virol"},{"key":"511_CR5","doi-asserted-by":"crossref","unstructured":"Clair St. MH, Furman PA, Lubbers CM, Elion GB. Inhibition of cellular \u03b1 and virally induced deoxyribonucleic acid polymerases by the triphosphate of acyclovir. Antimicrob Agents Chemother. 1980;18(5):741\u20135.","DOI":"10.1128\/AAC.18.5.741"},{"issue":"8","key":"511_CR6","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1021\/bi00008a014","volume":"34","author":"DD Ilsley","year":"1995","unstructured":"Ilsley DD, Lee SH, Miller WH, Kuchta RD. Acyclic guanosine analogs inhibit DNA polymerases \u03b1, \u03b4, and \u03b5 with very different potencies and have unique mechanisms of action. Biochemistry. 1995;34(8):2504\u201310.","journal-title":"Biochemistry"},{"issue":"2","key":"511_CR7","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S1383-5718(99)00159-X","volume":"446","author":"GC Jagetia","year":"1999","unstructured":"Jagetia GC, Aruna R. Effect of various concentrations of acyclovir on cell survival and micronuclei induction on cultured HeLa cells. Mutat Res Genet Toxicol Environ Mutagen. 1999;446(2):155\u201365.","journal-title":"Mutat Res Genet Toxicol Environ Mutagen"},{"issue":"1","key":"511_CR8","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1177\/12034754211037998","volume":"26","author":"A Elsayed","year":"2022","unstructured":"Elsayed A, Nassar A, Marei A, Hoseiny HAM, Alakad R. Intralesional acyclovir: a potential therapeutic option for cutaneous warts. J Cutan Med Surg. 2022;26(1):25\u201330.","journal-title":"J Cutan Med Surg"},{"issue":"2","key":"511_CR9","first-page":"237","volume":"15","author":"A Bagwell","year":"2016","unstructured":"Bagwell A, Loy A, McFarland MS, Tessmer-Neubauer A. Oral acyclovir in the treatment of verruca. J Drugs Dermatol. 2016;15(2):237\u20138.","journal-title":"J Drugs Dermatol"},{"issue":"1","key":"511_CR10","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1177\/0145561318823311","volume":"98","author":"S Mitra","year":"2019","unstructured":"Mitra S, Das A, Ghosh D, Sengupta A. Postoperative systemic acyclovir in juvenile-onset recurrent respiratory papillomatosis: the outcome. Ear Nose Throat J. 2019;98(1):28\u201331.","journal-title":"Ear Nose Throat J"},{"issue":"3","key":"511_CR11","first-page":"1","volume":"5","author":"KJ Looker","year":"2020","unstructured":"Looker KJ, Johnston C, Welton NJ, James C, Vickerman P, Turner KME, et al. The global and regional burden of genital ulcer disease due to herpes simplex virus: a natural history modelling study. BMJ Glob Heal. 2020;5(3):1\u201315.","journal-title":"BMJ Glob Heal"},{"issue":"January","key":"511_CR12","first-page":"1","volume":"8","author":"AJ Kombe Kombe","year":"2021","unstructured":"Kombe Kombe AJ, Li B, Zahid A, Mengist HM, Bounda GA, Zhou Y, et al. Epidemiology and burden of human papillomavirus and related diseases, molecular pathogenesis, and vaccine evaluation. Front Public Health. 2021;8(January):1\u201319.","journal-title":"Front Public Health"},{"key":"511_CR13","doi-asserted-by":"crossref","unstructured":"Spayne J, Hesketh T. Estimate of global human papillomavirus vaccination coverage: analysis of country-level indicators. BMJ Open. 2021;11(9).","DOI":"10.1136\/bmjopen-2021-052016"}],"container-title":["Infectious Agents and Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13027-023-00511-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13027-023-00511-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13027-023-00511-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T09:47:52Z","timestamp":1685699272000},"score":1,"resource":{"primary":{"URL":"https:\/\/infectagentscancer.biomedcentral.com\/articles\/10.1186\/s13027-023-00511-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,2]]},"references-count":13,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["511"],"URL":"https:\/\/doi.org\/10.1186\/s13027-023-00511-0","relation":{},"ISSN":["1750-9378"],"issn-type":[{"type":"electronic","value":"1750-9378"}],"subject":[],"published":{"date-parts":[[2023,6,2]]},"assertion":[{"value":"3 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The reported observations in this paper derived from MB\u2019s clinical practice. Patients voluntarily visited MB's outpatient clinic for conventional gynaecological treatment and gave their consent to use their medical records for scientific purpose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"After acceptance.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"36"}}